FDA Inspection 1339400 — ATSF NW Office
The FDA completed an inspection of ATSF NW Office on Sep 18, 2026 in Eau Claire, WI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 18, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Eau Claire, WI (United States)